BioVie, Inc. (BIVI)
1.625
+0.02
(+0.93%)
USD |
NASDAQ |
Sep 21, 16:00
1.625
0.00 (0.00%)
After-Hours: 20:00
BioVie Market Cap : 12.26M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 12.14M |
| September 17, 2026 | 13.43M |
| September 16, 2026 | 12.97M |
| September 15, 2026 | 13.20M |
| September 14, 2026 | 15.46M |
| September 11, 2026 | 14.56M |
| September 10, 2026 | 14.41M |
| September 09, 2026 | 14.86M |
| September 08, 2026 | 15.61M |
| September 04, 2026 | 15.09M |
| September 03, 2026 | 15.31M |
| September 02, 2026 | 15.31M |
| September 01, 2026 | 16.90M |
| August 31, 2026 | 17.20M |
| August 28, 2026 | 16.29M |
| August 27, 2026 | 16.52M |
| August 26, 2026 | 15.91M |
| August 25, 2026 | 15.76M |
| August 24, 2026 | 16.14M |
| August 21, 2026 | 14.71M |
| August 20, 2026 | 14.03M |
| August 19, 2026 | 10.11M |
| August 18, 2026 | 7.274M |
| August 17, 2026 | 8.825M |
| August 14, 2026 | 10.56M |
| Date | Value |
|---|---|
| August 13, 2026 | 11.77M |
| August 12, 2026 | 11.77M |
| August 11, 2026 | 9.579M |
| August 10, 2026 | 8.297M |
| August 07, 2026 | 7.536M |
| August 06, 2026 | 10.18M |
| August 05, 2026 | 15.39M |
| August 04, 2026 | 13.80M |
| August 03, 2026 | 12.22M |
| July 31, 2026 | 11.46M |
| July 30, 2026 | 10.78M |
| July 29, 2026 | 9.503M |
| July 28, 2026 | 10.03M |
| July 27, 2026 | 10.33M |
| July 24, 2026 | 10.33M |
| July 23, 2026 | 10.86M |
| July 22, 2026 | 10.11M |
| July 21, 2026 | 9.729M |
| July 20, 2026 | 10.75M |
| July 17, 2026 | 13.58M |
| July 16, 2026 | 12.97M |
| July 15, 2026 | 13.35M |
| July 14, 2026 | 11.92M |
| July 13, 2026 | 12.37M |
| July 10, 2026 | 17.12M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 354.14M |
| Amgen, Inc. | 212.69B |
| Anika Therapeutics, Inc. | 277.30M |
| BioCryst Pharmaceuticals, Inc. | 2.236B |
| Imunon, Inc. | 6.625M |
Market Cap Related Metrics
| Price to Book Value | 1.193 |
| Price | 1.625 |
| Earnings Yield | -196.8% |